logo
Loose Women Ruth Langsford's 'very difficult' ordeal amid mum's Alzheimer's fight

Loose Women Ruth Langsford's 'very difficult' ordeal amid mum's Alzheimer's fight

Daily Mirrora day ago
Ruth Langsford's mother is facing a health battle, 13 years after her dad died from the same condition
Ruth Langsford has opened up about juggling a hectic TV career with caring for her mother, Joan. The Loose Women star's parent, now 94, is fighting Alzheimer's disease - the same condition that claimed her father's life 13 years ago.

Joan is now experiencing various challenging symptoms, such as memory loss, and Ruth consistently cares for her. She currently resides in a care home near Ruth's house in Surrey.

Discussing her mother, Ruth said: "She wouldn't remember what she's had for her lunch or breakfast, and if I go and see her, when I leave, if you said to her was Ruth here today, she'd say no. But in the moment, she still knows it's me – as soon as she sees me, she says 'Oh, what a lovely surprise!' like she hasn't seen me for months.

"It's very difficult, but I'm much more well-versed in this with my mum, because of my dad. We as a family had no idea about Alzheimer's or dementia when he got it, and we were a bit lost. I learned a lot of lessons with my dad."
Joan cared for Ruth's father at their home in Cornwall for about 11 years before they eventually moved closer to the TV presenter. "It was a struggle for her towards the end," Ruth continued.

"He would get up in the middle of the night and he flushed his pyjamas down the loo once and flooded the bathroom. It was awful. And she wouldn't tell my sister and I sometimes, because we lived a long way away.
"But eventually we realised how bad it had got, and she eventually agreed that he should go into a home." Ruth stressed that because her mum is now in a care home too, she's not looking after her 24/7.
She went on: "I don't have that day-to-day care of cooking, cleaning, all those things, but I am still her main carer. So if they say your mum needs to see the doctor, or the dentist, or she needs some shower gel and toothpaste, then that does come down to me.

"And just generally I go in, I take her fruit, I take her flowers, I check the room, I look at her wardrobe, make sure things are hung in the right place. It's care with love, isn't it?"
Ruth's caring responsibilities have led her to back a new partnership between the charity Dementia Carers Count and Amazon to help unpaid carers maximise the use of Alexa-enabled devices.

They have created a free visual guide that showcases key Alexa features, such as advanced scheduling tools to assist carers in managing daily routines and feeling more supported. This comes after research by Dementia Carers Count revealed that 71% of unpaid carers lack sufficient support, with over a third (36%) describing their role as a round-the-clock responsibility.
"The thing that stood out to me is the reminders, because I'm very good at putting things in the diary like Mum's dental appointment, and forgetting to check it," Ruth said. "So the fact that you can have a visual and an audio reminder is a great function for me."
She then added wryly: "Actually, using the words 'remembering to do it' is kind of ironic, isn't it, when we're talking about dementia?" Ruth, who shares a 23-year-old son, Jack, with Eamonn Holmes, also described how challenging life can be for unpaid carers. She highlighted that anyone caring for loved ones needs all the support they can get.

She continued: "So many people I know, including myself – I think they call us the sandwich generation don't they – have got possibly a full-time job, kids still at home, and often parents that need some help, and it's a lot for people to manage.
"Responsibility like that can weigh very heavily on people, and even though it's somebody that you really love and you want to take care of them, it's difficult and you feel responsible, especially if it's people doing it on their own – it can be very lonely being a carer. And some of them are doing this 24/7 on their own, which I think is very, very difficult. And they need all the support they can get."
With both her mum and dad having suffered from Alzheimer's, Ruth confessed that she experiences moments of fear whenever she has a memory lapse, wondering whether she might be developing the condition herself.

However, she has no plans to undergo testing to determine her risk of getting dementia, revealing: "Every time I forget something, those blank moments where you go 'I've totally forgotten that person's name, and I work with them every day', I can feel that panic.
"And sometimes I look back and think, I was tired that day, but when you've had both parents with dementia of course it's on my mind, and I know there are tests you can do that can say if you're more susceptible, but I actually don't want to know.
"That might sound a bit childlike, but as there's no cure for it, and I know what it involves, I don't want to know. I just want to live my life. If I get it, I get it. I hope not."

Rather than fretting about dementia, Ruth says she has embraced living life to the fullest, genuinely relishing her career and maintaining a packed schedule. "You won't come around here on an afternoon and find me lying on the sofa watching a film," she said. "Because I'm always pottering about, I've got things to do."
In her spare time, Ruth enjoys putting music on and cooking, gardening, walking her dog Maggie and switching her phone off. "I just try and walk with no earphones in, just walking, breathing in the fresh air, walking my dog in nature," she said.
"And honestly, I love my work. I'm very lucky. Of course, there are days when I wish I didn't have to go in because I'm tired or whatever, but I never dread going to work. I love my job, and I'm very fortunate."
The 65-year-old star later added: "I feel fit, and I've started doing Pilates again, which I'm really enjoying. As I get older I've started thinking I've got to keep supple and keep my joints moving, but I have no intention of slowing down or retiring."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Popular hair growth cream recalled over risk of 'serious injury or death from poisoning'
Popular hair growth cream recalled over risk of 'serious injury or death from poisoning'

Daily Mail​

time2 hours ago

  • Daily Mail​

Popular hair growth cream recalled over risk of 'serious injury or death from poisoning'

Officials are raising the alarm over a popular hair loss serum sold nationwide that could cause serious injury and death. Sefralls Minoxidil Hair Generation Serum, sold in amber dropper bottles for $10 on Amazon, is being recalled because it is not in child-resistant packaging. The US Consumer Product Safety Commission, which announced the recall, warned children could accidentally open and consume the minoxidil-laced fluid. Scientists say that consuming just a few ounces of minoxidil, an over-the-counter medication approved by the FDA to reverse hair loss, can cause blood vessels to become dangerously relaxed, triggering extremely low blood pressure. This can cause the heart to shut down, start beating erratically or go into heart failure, and cause death. It can also pose a serious hazard to pets if ingested. About 21,300 units of the product have been recalled and were distributed in the US from June 2024 to June 2025. No injuries or deaths have been reported to date. Guangzhou Ariel Biotech, the Chinese company behind the product, has urged customers to immediately place recalled bottles out of sight or reach of children and contact them for instructions on how to destroy the bottles. It is offering to send replacements to customers who pour the contents of the bottle into the trash, photograph it and send the image to the company. Officials said customers could identify whether their minoxidil had been recalled by whether it mentioned 'Sefralls' and 'minoxidil' on the label. The bottles sold also had a white and gold dropper and a white, black and gold label. The recall is thought to affect every bottle of Sefralls Minoxidil Hair Generation Serum sold in the US. In the recall notice on August 7, the CPSC wrote: 'The hair serum's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.' All bottles of minoxidil sold in the US are required to be child resistant under the 1970 Poison Prevention Packaging Act. Officials included minoxidil in the act amid mounting concerns over the risk the drug posed to small children. There are no publicly reported fatalities in the US to date among young children who accidentally consumed minoxidil. Minoxidil has exploded in popularity in recent years, alongside hair loss drug finasteride, with about 13million Americans estimated to use the drug in 2024. The US hair loss market has also surged in value, with estimates suggesting it will more than double from a value of $2.84billion to more than $5.26billion over the next decade. The drug works by boosting blood flow to the areas surrounding hair follicles, which can stimulate hair regrowth and restore hair in previously bald patches. It is formulated in low concentrations in hair loss treatments to achieve this effect safely, minimizing the risk to patients. If consumed, doctors treat patients by administering large amounts of fluids and medications to raise blood pressure. The FDA has only approved minoxidil as a drug for treating hair loss. It is at least the second recall over minoxidil being sold in non-child safe bottles in as many months, after another recall was issued in late July for Aemerry Hair Growth Serums, which also was not sold in child-resistant packaging. About 2,300 bottles of the hair growth serums were sold online at from March to June this year for about $22 each. They were sold in black-tinted bottles with droppers for dispensing the serums and navy blue labels with blue and white lettering. The front of the bottles read: 'Aemerry Clinically Proven To Help Regrow Beard 5% Minoxidil with Biotin.' No injuries or deaths have been reported to date, and consumers are being urged to throw out the bottles.

Cats develop dementia similarly to humans
Cats develop dementia similarly to humans

Leader Live

time5 hours ago

  • Leader Live

Cats develop dementia similarly to humans

Experts at the University of Edinburgh carried out a post-mortem brain examination on 25 cats which exhibited symptoms of dementia in life, including confusion, sleep disruption and an increase in vocalisation, in a bid explore new treatments for humans. Previously, researchers have studied genetically modified rodents, although the species does not naturally suffer from dementia. In feline dementia brains, a build-up was found of amyloid-beta, a toxic protein and one of the defining features of Alzheimer's disease, leading to hopes of a 'wonderful' breakthrough due to increased accuracy. The breakthrough was hailed as a 'perfect natural model for Alzheimer's' by scientists who worked on it. Microscopy images revealed a build-up of amyloid-beta within synapses of older cats and feline dementia, and scientists hope the findings offer a clearer idea of how amyloid-beta may lead to feline cognitive dysfunction and memory loss, offering a valuable model for studying dementia in people. Synapses allow the flow of messages between brain cells, and losing these causes reduced memory and thinking abilities in humans with Alzheimer's. Researchers found evidence that brain support cells, astrocytes and microglia, engulfed the affected synapses, known as synaptic pruning, an important process during brain development but which contributes to dementia. Experts believe the findings could contribute to the development of new treatments for Alzheimer's disease, as well as help to understand and manage feline dementia. Previously, scientists studying Alzheimer's relied on genetically modified rodent models. However, studying feline dementia has the potential to help develop human treatments, due to increased accuracy, it is hoped. The study, funded by Wellcome and the UK Dementia Research Institute, is published in the European Journal of Neuroscience, and included scientists from the Universities of Edinburgh and California, UK Dementia Research Institute and Scottish Brain Sciences. Dr Robert McGeachan, study lead from the University of Edinburgh's Royal (Dick) School of Veterinary Studies, said: 'Dementia is a devastating disease – whether it affects humans, cats, or dogs. Our findings highlight the striking similarities between feline dementia and Alzheimer's disease in people. 'This opens the door to exploring whether promising new treatments for human Alzheimer's disease could also help our ageing pets. 'Because cats naturally develop these brain changes, they may also offer a more accurate model of the disease than traditional laboratory animals, ultimately benefiting both species and their caregivers.' Professor Danielle Gunn-Moore, personal chair of Feline Medicine at the Royal (Dick) School of Veterinary Studies, said: 'Feline dementia is so distressing for the cat and for its person. 'It is by undertaking studies like this that we will understand how best to treat them. This will be wonderful for the cats, their owners, people with Alzheimer's and their loved ones. 'Feline dementia is the perfect natural model for Alzheimer's – everyone benefits.'

Cats develop dementia similarly to humans
Cats develop dementia similarly to humans

Rhyl Journal

time7 hours ago

  • Rhyl Journal

Cats develop dementia similarly to humans

Experts at the University of Edinburgh carried out a post-mortem brain examination on 25 cats which exhibited symptoms of dementia in life, including confusion, sleep disruption and an increase in vocalisation, in a bid explore new treatments for humans. Previously, researchers have studied genetically modified rodents, although the species does not naturally suffer from dementia. In feline dementia brains, a build-up was found of amyloid-beta, a toxic protein and one of the defining features of Alzheimer's disease, leading to hopes of a 'wonderful' breakthrough due to increased accuracy. The breakthrough was hailed as a 'perfect natural model for Alzheimer's' by scientists who worked on it. Microscopy images revealed a build-up of amyloid-beta within synapses of older cats and feline dementia, and scientists hope the findings offer a clearer idea of how amyloid-beta may lead to feline cognitive dysfunction and memory loss, offering a valuable model for studying dementia in people. Synapses allow the flow of messages between brain cells, and losing these causes reduced memory and thinking abilities in humans with Alzheimer's. Researchers found evidence that brain support cells, astrocytes and microglia, engulfed the affected synapses, known as synaptic pruning, an important process during brain development but which contributes to dementia. Experts believe the findings could contribute to the development of new treatments for Alzheimer's disease, as well as help to understand and manage feline dementia. Previously, scientists studying Alzheimer's relied on genetically modified rodent models. However, studying feline dementia has the potential to help develop human treatments, due to increased accuracy, it is hoped. The study, funded by Wellcome and the UK Dementia Research Institute, is published in the European Journal of Neuroscience, and included scientists from the Universities of Edinburgh and California, UK Dementia Research Institute and Scottish Brain Sciences. Dr Robert McGeachan, study lead from the University of Edinburgh's Royal (Dick) School of Veterinary Studies, said: 'Dementia is a devastating disease – whether it affects humans, cats, or dogs. Our findings highlight the striking similarities between feline dementia and Alzheimer's disease in people. 'This opens the door to exploring whether promising new treatments for human Alzheimer's disease could also help our ageing pets. 'Because cats naturally develop these brain changes, they may also offer a more accurate model of the disease than traditional laboratory animals, ultimately benefiting both species and their caregivers.' Professor Danielle Gunn-Moore, personal chair of Feline Medicine at the Royal (Dick) School of Veterinary Studies, said: 'Feline dementia is so distressing for the cat and for its person. 'It is by undertaking studies like this that we will understand how best to treat them. This will be wonderful for the cats, their owners, people with Alzheimer's and their loved ones. 'Feline dementia is the perfect natural model for Alzheimer's – everyone benefits.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store